Clinical-epidemiologist characterization of the trombolized acute myocardial infarction in the Adult Intensive Care unit.
Abstract
An observational, descriptive, prospective study was carried out with the objective to characterize some clinical and epidemiological factors related to the trombolized acute myocardial infarction, in patients admitted at the Adult Intensive Care Units of the General Teaching Hospital of Moron from January 1st to December 31st 2011. The universe was constituted by all patients with acute myocardial infarction diagnosis and the sample by patients dealt with recombinant streptokinase. Simple statistical was the used method through summary measures for qualitative and quantitative variables. Arterialhypertension and smoking were the most frequent risk factors. Most of the patients were taken care of within the first 6 hours of their arrival at the Emergency Service. The more frequent electrocardiographic presentation form was with ST elevation. The greater percent of the thrombolysis was made in the first time of arrival to the emergency department. The arterial hypotension was the more frequent adverse reaction. There were electrical complications. It was found the lightening of the pain and the ST segment depression as the most frequent reperfusion criteria.
Downloads
Author Biographies
Bernardo Luis Balmori Marin
Ignacio Martínez Rodríguez
Ezequiel Suárez Yanes
Yamaris Calero Pérez
References
Infarto agudo del miocardio. En: Caballero L. Terapia Intensiva. 2da ed. La Habana: Editorial de Ciencias Médicas; 2009. p.1381-99.
Braunwald E. Unstable angina: an etiologic approach to management. Circulation. 2006; 98(21):2219-22.
Roca Goderich R. Cardiopatía isquémica. En: Roca Goderich R, Smith Smith V, Paz Presilla E, Losada Gómez E, Serret Rodríguez B, Llamos Sierra N, et al. Temas de medicina interna. 4a ed. La Habana: Editorial de Ciencias Médicas; 2002. p. 392-418.
Harrison. Principios de medicina interna. 15va ed. México: Editorial Interamericana; México, 2005.
Cuba. Ministerio de Salud Pública. Centro Nacional Coordinador de Ensayos Clínicos. Aplicación de la estreptoquinasa recombinante en el infarto agudo del miocardio. Extensión Nacional “Estudio clínico fase IV”, Multicentro IG/Ski/IM/92 Nov; 1995: p.12- 25.
Julián DB. Angina pectoris. Descripción completa de los antecedentes históricos, epidemiología, pronóstico, hemodinamia, clasificación clínica, exploración física, datos de laboratorio y tratamiento médico y quirúrgico de la angina de pecho. New York: Dalmao Publishers; 2009.
Zapata G, Pirillo I, Tuero E, Orlandini A, Padlasso E, Díaz R. Análisis de estrategias de reperfusión, tiempo desde el inicio de los síntomas y mortalidad en 223 pacientes consecutivos ingresados al Instituto Cardiovascular de Rosario (ICR). XVIII Congreso Nacional de Cardiología. Buenos Aires; 2007.
Zapata G, Namioli D. Por el comité de unidad coronaria de la Sociedad de Cardiología de Rosario. Relevamiento epidemiológico y de mortalidad de todos los UCC de la unidad de Rosario. 4ª reunión plenaria de la Sociedad de Cardiología de Rosario; 2007.
Braunwald E, Selwin AP. Ischemic heart disease. In: Braunwald E, Isselbacher JK, Peterdorf RG, Wilson JD, Martin JB, Fucias AS. Harrison’s principles of internal medicine. 11 ed. New York: McGraw Hill; 2008.
Samama E. Cardiopatía isquémica. En: Szwarcer E, Samama E. Drogas trombolíticas. 1ª ed. Argentina: Gador; 2010. p. 458-9.
Fuster V, Badimon L, Badimon J, Enesidro J. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 2009; 326:245-50.
Paolasso E, Boccanera V. Manejo y tratamiento del infarto agudo del miocardio con supradesnivel del ST. Rev FAC [Internet]. 2009 [17 Ene 2003]; II Congreso Virtual de Cardiología. 18(1):1-21. Disponible en: http://www.apacher@satlink.com/manejoy tratamiento ST.htm
Topol EJ, Futer V. Unstable angina. In: Cardiovascular thrombosis. Thrombocardiology and thromboneurology. Philadelphia: Lippincott-Raven; 2007. p. 475-99.
Quirós Luis JJ, Elizalde Díaz R, Castillo Guzmán A. Reducción del tiempo puerta-aguja en el cuerpo de guardia con el tratamiento trombolítico. Rev Cubana Cardiol Cir Cardiovasc. 1999; 13(2):116-21.
Armstrong PW, Fu Y, Chong WC, Topol EJ, Grauger CB, Bedrin A, et al. Califf RM acute coronary syndromes in the Gusto IIb trial: prognostic irrigats and impact of recurrent ischemia. The Gusto IIb Investigators. Circulation. 2005; 98(18):1860-8.
Simoors M, Arnold A. Tailored thrombolytic therapy: a perspective. Circulation. 1993; 88:2556.
Hamm CW.et al: emergency room triage of pacients with acute chest pain bymeans of rapid testing for cardiac troponin T or troponin I. N Engl J Med. 1997; 337: 1648.
Bono J, Fernández C, Arballo C, Suasnábar R, Flores L, Paganini C. Arritmias en el IAM. Disociación electromecánica. Complicaciones mecánicas. Rev FAC [Internet]. 2000 [17 Ene 2003]; I Congreso Virtual de Cardiología. 3(1):1-18. Disponible en: http://www.apacher@satlink.com/arritmias en el IAM.htm
Adams JE, III Abendecheir Dr, Jaffe AS. Biochemical markers of myocardial injury. Is MB creatine kinase the choice of the 1990s? Circulation. 1993; 88(2):750-63.
Pathy MS. Clinical presentation of myocardial infarction in the elderly. Br Heart J. 1967; 29: 190-9.
Downloads
Published
How to Cite
Issue
Section
License
Those authors who have publications with this journal accept the following terms of the License CC Attribution-NonCommercial 4.0 International (CC BY-NC 4.0):
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes .
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
